医学
疾病
Pet成像
Tau病理学
阿尔茨海默病
神经科学
核医学
正电子发射断层摄影术
病理
心理学
作者
Farahnaz Aghahosseini,Yalda Salehi,Saeed Farzanefar,Mohsen Bakhshi Kashi,Elisabeth Eppard,Hojjat Ahmadzadehfar,Siroos Mirzaei,Nasim Vahidfar,Ayuob Aghanejad
标识
DOI:10.2174/0118744710314668240718070109
摘要
Dementia (the most common cause of Alzheimer's disease) is defined as a chronic or progressive syndrome with disturbance of multiple cortical functions, the most important of them including memory, learning capacity, comprehension, orientation, calculation, language, and judgement. These cognitive impairments affect the quality of life, behavior, and social relations. Techniques of nuclear medicine provide feasible ways to record the intracellular alterations of disease and deficiencies. In these non-invasive manners, the hippocampal-neocortical disconnection may partly explain the hypo-metabolism incident found in Alzheimer's disease. Based on this fact, the study of all these mechanisms of action is conceivable and achievable by radiopharmaceuticals. This review is aimed at the presentation of radiopharmaceuticals that are developed for the detection of Alzheimer's disease in preclinical and clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI